BRWA
ANAC

B. Riley Wealth Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

B. Riley Wealth Advisors’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-21,498
Closed -$120K – 797
2013
Q2 		$120K Buy
+21,498
New +$130K 0.04% 499

Other funds holding ANAC

RCP
Rho Capital Partners New York $20.4M AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

B. Riley Wealth Advisors's ANAC Position: Q3 2013 in Review

B. Riley Wealth Advisors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q3 2013, closing a stake of 21,498 shares — an estimated $120K sold.

B. Riley Wealth Advisors first reported a position in ANAC in Q2 2013 and held it in 1 quarter. The position peaked at $120K in Q2 2013. 78 funds tracked by Wall St. Rank hold ANAC as of Q3 2013.

  • B. Riley Wealth Advisors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q3 2013 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 21,498 ANACOR PHARMACEUTICALS INC COM shares in Q3 2013, an estimated $120K.
  • B. Riley Wealth Advisors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 1 quarter.
  • B. Riley Wealth Advisors's ANACOR PHARMACEUTICALS INC COM position peaked at $120K in Q2 2013.
  • 78 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q3 2013.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2013, filed 21 Oct 2013.